Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001)

Clinical trial NCT05721222 · TERMINATED

Trial details

NCT number: NCT05721222
Sponsor: Genmab
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma Nasopharyngeal Carcinoma Non Hodgkin Lymphoma

Start date: 2023-03-15
Primary completion: 2025-11-05
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.